Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +7.46% | 0.00% | -0.35% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.35% | 25.19M | |
+33.34% | 664B | |
+29.29% | 567B | |
-7.14% | 354B | |
+19.12% | 330B | |
+4.74% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.69% | 148B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Transcript : Acasti Pharma Inc. - Shareholder/Analyst Call